Loading the session
Loading the session
Loading instrument
$203.87
−5.96%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 02:30 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 close of $206.72 was 15.6% below its 50-day average ($245.04) and 14.2% below its 200-day average ($240.82). It has closed below the 200-day for 10 sessions, since 22 Oct 2026. The 50-day average crossed above the 200-day on 6 Oct 2025, 272 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
1 month: −24.2% (SPY −1.6%, XLK −12.6%). 3 months: −24.7% (SPY −0.4%, XLK −5.1%). 1 year: +48.2% (SPY +13.6%, XLK +20.1%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: PLXS, SPY and XLK · as of 4 Nov 2026
29 Oct 2026 volume of 694.0K shares was 2.5× the average of the 30 sessions before it (272.7K), as the price fell 9.6%. SPY traded 1.0× its own average that session.
Daily volume against a 30-session baseline · as of 29 Oct 2026
Trailing P/E of 30.1 against a median of 29.4 across 3 peers named in its company record (range 27.9 to 46.1).
Quote feed P/E (price ÷ trailing 12-month EPS); peers as named in the company record · as of 4 Nov 2026
Closed at $206.72 on 4 Nov 2026: 32.7% below the 52-week high of $307.06 (22 Jun 2026) and 56.6% above the low of $132.03 (21 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
July 24, 2025
−11.61%April 9, 2025
+12.17%January 26, 2023
−17.11%